Загрузка...
Chronic treatment with hydroxychloroquine and SARS‐CoV‐2 infection
Hydroxychloroquine sulfate (HCQ) is being scrutinized for repositioning in the treatment and prevention of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. This antimalarial drug is also chronically used to treat patients with autoimmune diseases. By analyzing the Portuguese a...
Сохранить в:
| Опубликовано в: : | J Med Virol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361589/ https://ncbi.nlm.nih.gov/pubmed/32644224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26286 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|